• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations & Treatment

Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations & Treatment

9781607413981
2,312.04 zł
2,080.83 zł Save 231.21 zł Tax included
Lowest price within 30 days before promotion: 2,080.83 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. It may also be referred to as multidrug-resistant Staphylococcus aureus. MRSA is by definition a strain of Staphylococcus aureus that is resistant to a large group of antibiotics called the beta-lactams, which include the penicillins and the cephalosporins. MRSA was identified as a nosocomial pathogen in the 1960s. MRSA acquisition has traditionally been linked to health care settings and specific patient populations. Established risk factors for MRSA infection include older age, recent hospitalisation or surgery, past antimicrobial therapy, residence in a long-term care facility, dialysis, indwelling percutaneous devices and catheters. This important book gathers the latest research from around the globe in this field and focuses on such topics as:: risk factors for MRSA in a paediatric surgical ward, MRSA treatments, the anatomy of an outbreak, and others.
Product Details
72855
9781607413981
9781607413981

Data sheet

Publication date
2010
Issue number
1
Cover
hard cover
Pages count
562
Dimensions (mm)
260.00 x 180.00
Weight (g)
1048
  • Preface; The Case for MRSA & Treatment of Methicilllin Resistant Staphylococcus aureus; Therapeutic options for intracellular MRSA:: Current views & perspectives; Methicillin-Resistant Staphylococcus Aureus (MRSA); Hospital & Community-Acquired Methicillin-Resistant Staphylococcus Aureus Bone & Joint Infections; MRSA:: The Virulence, Epidemiology & Perspective Diagnostics & Therapy; Recent Advances in Medicinal Chemistry of New Quinolones with Potential Anti-MRSA Activity; Methicillin-Resistant Staphylococcus aureus:: Etiology, At-Risk Populations & Treatment; Multidrug-Resistant Acinetobacter Baumannii Infections:: Characteristics & Treatment Options; The Anatomy of an Outbreak:: Lessons Learned from an Outbreak of Methicillin-Resistant Staphylococcus aureus Among Newborns & a Review of the Literature; The Emerging & the Re-Emerging of Antimicrobial-Resistant Gram-Positive Cocci:: Evidences Supporting Novel Pharmaceutical Weapons; DHEA-Mediated Phenotypic Alterations in Staphylococcal Cell Wall Architecture; Risk Factors for Carrying Methicillin-Resistant Staphylococcus aureus at Hospitalization in a Pediatric Surgical Ward; Populations At-Risk for Methicillin-Resistant Staphylococcus aureus Infection; Staphylococcus aureus:: Risk Factors for Oronasal Transmission & Dental Aspect; Community-Associated Methicillin-Resistant Staphylococcus aureus:: Etiology, Diagnosis, Prevention & Treatment; Community-Acquired Methicillin-resistant Staphylococcus aureus:: Characterization, Risk Factors, & Treatment; The Changing Pattern of Infections with MRSA & Other Organisms after Major Reconstructive Surgery of the Maxillofacial Region; The Phenomenon of Antibiotic Resistance in an Evolutionary Perspective; Index.
Comments (0)